Compare Moderna, Inc. (MRNA) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Tyson Foods, Inc. — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Tyson Foods, Inc. trades at $57.25 (market cap $20.42B). The key difference: Moderna, Inc. is the larger of the two by market cap, and Tyson Foods, Inc. pays a 3.52% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | TSN | |
|---|---|---|
Market Cap | $23.60B | $20.42B |
Sector | Health | Consumer Staples |
52-Week High | $81.80 | $68.75 |
52-Week Low | $22.36 | $50.72 |
Enterprise Value | $19.70B | $28.01B |
Dividend Yield | — | 3.52% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
